Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies

P. Schoffski, H. Dumez, R. Ruijter, B. Miguel-Lillo, A. Soto-Matos, V. Alfaro, G. Giaccone

Research output: Contribution to journalArticleAcademicpeer-review

25 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1397-1403
JournalCancer Chemotherapy and Pharmacology
Volume68
Issue number6
DOIs
Publication statusPublished - 2011

Cite this

@article{4956ce62888347f9b0750275bfd0193e,
title = "Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies",
author = "P. Schoffski and H. Dumez and R. Ruijter and B. Miguel-Lillo and A. Soto-Matos and V. Alfaro and G. Giaccone",
year = "2011",
doi = "10.1007/s00280-011-1612-1",
language = "Undefined/Unknown",
volume = "68",
pages = "1397--1403",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "6",

}

Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies. / Schoffski, P.; Dumez, H.; Ruijter, R.; Miguel-Lillo, B.; Soto-Matos, A.; Alfaro, V.; Giaccone, G.

In: Cancer Chemotherapy and Pharmacology, Vol. 68, No. 6, 2011, p. 1397-1403.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies

AU - Schoffski, P.

AU - Dumez, H.

AU - Ruijter, R.

AU - Miguel-Lillo, B.

AU - Soto-Matos, A.

AU - Alfaro, V.

AU - Giaccone, G.

PY - 2011

Y1 - 2011

U2 - 10.1007/s00280-011-1612-1

DO - 10.1007/s00280-011-1612-1

M3 - Article

VL - 68

SP - 1397

EP - 1403

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 6

ER -